Susan Morrison - Oct 13, 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
EVP & Chief Admin. Officer
Signature
s/ David B. Berger, Attorney-in-Fact for Susan M. Morrison
Stock symbol
TNDM
Transactions as of
Oct 13, 2021
Transactions value $
-$1,128,488
Form type
4
Date filed
10/14/2021, 04:56 PM
Previous filing
Aug 31, 2021
Next filing
Nov 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $45.8K +4.15K +51.29% $11.06 12.2K Oct 13, 2021 Direct F1
transaction TNDM Common Stock Options Exercise $53.1K +5.9K +48.28% $9.00 18.1K Oct 13, 2021 Direct F1
transaction TNDM Common Stock Sale -$1.33M -10K -55.42% $132.01 8.08K Oct 13, 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Common Stock Options Exercise $45.8K +4.15K $11.06 0 Oct 13, 2021 Common Stock 4.15K $11.06 Direct F4, F5
transaction TNDM Common Stock Options Exercise $53.1K +5.9K $9.00 0 Oct 13, 2021 Common Stock 5.9K $9.00 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon exercise of a stock option award.
F2 The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 6, 2021.
F3 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $132.00 to $132.70. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F4 The option vested as to twenty-five percent (25%) of the underlying shares on 04/23/2014, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter.
F5 The expiration date for these options is 10 years from the date of grant.
F6 The options vested as to twenty-five percent (25%) of the underlying shares on 5/17/2018, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").